Actively Recruiting
Cohort of IPF Patients Experiencing an Exacerbation
Led by University Hospital, Gentofte, Copenhagen · Updated on 2023-12-22
50
Participants Needed
1
Research Sites
446 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Extension of the PFBIO cohort which includes patients with newly diagnosed idiopathic pulmonary fibrosis (IPF) for longitudinal follow-up for up to 5 years. In the PFBIO-EXA extension, patients are included if they experience an exacerbation, or other increase in respiratory symptoms requiring hospital admission, for further collection of clinical and biological data.
CONDITIONS
Official Title
Cohort of IPF Patients Experiencing an Exacerbation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Admitted with an increase in respiratory symptoms
- Already included in PFBIO or included simultaneously in PFBIO and PFBIO-EXA
- Age at least 18 years
You will not qualify if you...
- Unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Herlev and Gentofte Hospital
Hellerup, Copenhagen, Denmark, 2900
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here